IL162769A0 - Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen - Google Patents

Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen

Info

Publication number
IL162769A0
IL162769A0 IL16276903A IL16276903A IL162769A0 IL 162769 A0 IL162769 A0 IL 162769A0 IL 16276903 A IL16276903 A IL 16276903A IL 16276903 A IL16276903 A IL 16276903A IL 162769 A0 IL162769 A0 IL 162769A0
Authority
IL
Israel
Prior art keywords
endogenousestrogen
thesynthesis
tibolone
associatedwith
complaints
Prior art date
Application number
IL16276903A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL162769A0 publication Critical patent/IL162769A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16276903A 2002-01-22 2003-01-16 Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen IL162769A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075235 2002-01-22
PCT/EP2003/000373 WO2003061665A1 (en) 2002-01-22 2003-01-16 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen

Publications (1)

Publication Number Publication Date
IL162769A0 true IL162769A0 (en) 2005-11-20

Family

ID=27589110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16276903A IL162769A0 (en) 2002-01-22 2003-01-16 Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen

Country Status (16)

Country Link
US (1) US20050124592A1 (es)
EP (1) EP1469861A1 (es)
JP (1) JP2005518412A (es)
KR (1) KR20040073572A (es)
CN (1) CN1620298A (es)
BR (1) BR0306789A (es)
CA (1) CA2472240A1 (es)
EC (1) ECSP045179A (es)
HR (1) HRP20040635A2 (es)
IL (1) IL162769A0 (es)
IS (1) IS7338A (es)
MX (1) MXPA04007071A (es)
PL (1) PL371181A1 (es)
RU (1) RU2004125594A (es)
WO (1) WO2003061665A1 (es)
ZA (1) ZA200405262B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
EP0613687B1 (en) * 1993-03-05 1999-06-02 Akzo Nobel N.V. Use of a pregnane derivatives for the treatment of tumours
EP1102755B1 (en) * 1998-08-07 2006-01-04 Chiron Corporation Substituted isoxazole derivatives as estrogen receptor modulators

Also Published As

Publication number Publication date
US20050124592A1 (en) 2005-06-09
ZA200405262B (en) 2005-08-31
BR0306789A (pt) 2004-12-28
JP2005518412A (ja) 2005-06-23
EP1469861A1 (en) 2004-10-27
PL371181A1 (en) 2005-06-13
WO2003061665A1 (en) 2003-07-31
CN1620298A (zh) 2005-05-25
ECSP045179A (es) 2004-08-27
IS7338A (is) 2004-06-28
MXPA04007071A (es) 2004-10-29
HRP20040635A2 (en) 2004-10-31
KR20040073572A (ko) 2004-08-19
RU2004125594A (ru) 2005-03-10
CA2472240A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
HK1073997A1 (en) Administration of agents for the treatment of inflammation
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
ZA200410229B (en) Administration of therapeutic viruses
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
SI1807156T1 (sl) Nove farmacevtske oblike za uporabo pri zdravljenju nespečnosti
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
IL149377A0 (en) Pharmaceutical formulation comprising melatonin
ZA200210316B (en) Composition and its therapeutic use.
PL374858A1 (en) Novel arylimidazole derivatives, preparation and therapeutic uses thereof
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
EP1485077A4 (en) DRUGS COMBINATION THERAPY
GB0327493D0 (en) Treatment medicament
IL165085A0 (en) Progestagenic dosage units
AU2003283508A8 (en) .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof
GB0208324D0 (en) Administration of beneficial substances
SI1525198T1 (sl) Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP
SI1525193T1 (sl) Acilaminotiazolni derivati in njihova uporaba kotinhibitorji beta-amiloida
SI1513835T1 (sl) Derivati piperazunilacilpiperidina, njihova priprava in njihova terapevtska uporaba